These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28941312)

  • 1. The Dual Role of Treg in Cancer.
    Frydrychowicz M; Boruczkowski M; Kolecka-Bednarczyk A; Dworacki G
    Scand J Immunol; 2017 Dec; 86(6):436-443. PubMed ID: 28941312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of regulatory T cells in cancer immunity.
    Takeuchi Y; Nishikawa H
    Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of costimulatory and inhibitory receptors in FoxP3
    Toker A; Ohashi PS
    Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxP3
    Saleh R; Elkord E
    Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory T cells, as a target in anticancer immunotherapy.
    Enokida T; Nishikawa H
    Immunotherapy; 2017 Jun; 9(8):623-627. PubMed ID: 28653572
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy.
    Schabowsky RH; Madireddi S; Sharma R; Yolcu ES; Shirwan H
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1002-8. PubMed ID: 18058571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced regulatory T cells in inhibitory microenvironments created by cancer.
    Whiteside TL
    Expert Opin Biol Ther; 2014 Oct; 14(10):1411-25. PubMed ID: 24934899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXP3+ Tregs: heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer.
    Zhuo C; Xu Y; Ying M; Li Q; Huang L; Li D; Cai S; Li B
    Immunol Res; 2015 Mar; 61(3):338-47. PubMed ID: 25608795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations.
    Ge J; Yin X; Chen L
    Front Immunol; 2024; 15():1457189. PubMed ID: 39290699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-regulatory T cell vaccines in immunotherapy: focusing on FoxP3 as target.
    Mousavi-Niri N; Naseroleslami M; Hadjati J
    Hum Vaccin Immunother; 2019; 15(3):620-624. PubMed ID: 30633616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
    Overacre-Delgoffe AE; Vignali DAA
    Cancer Immunol Res; 2018 Aug; 6(8):882-887. PubMed ID: 30068755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?
    Schipmann S; Wermker K; Schulze HJ; Kleinheinz J; Brunner G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1827-33. PubMed ID: 25087653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential targeting of B7-H4 for the treatment of cancer.
    Podojil JR; Miller SD
    Immunol Rev; 2017 Mar; 276(1):40-51. PubMed ID: 28258701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNFR2-expressing CD4
    He J; Li R; Chen Y; Hu Y; Chen X
    Prog Mol Biol Transl Sci; 2019; 164():101-117. PubMed ID: 31383403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.
    Luo CT; Liao W; Dadi S; Toure A; Li MO
    Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells in cancer immunosuppression - implications for anticancer therapy.
    Togashi Y; Shitara K; Nishikawa H
    Nat Rev Clin Oncol; 2019 Jun; 16(6):356-371. PubMed ID: 30705439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation in the Tumor Microenvironment.
    Lin Q; Jin S; Han M; Zheng W; Liu J; Wei X
    J Immunol Res; 2018; 2018():1965847. PubMed ID: 30035130
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of heterogeneous regulatory T cells in the tumor microenvironment.
    Wei T; Zhong W; Li Q
    Pharmacol Res; 2020 Mar; 153():104659. PubMed ID: 31982490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.